OOIR: Observatory of International Research

Papers

(The median citation count of Cellular & Molecular Biology Letters is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review	139
Targeting microRNAs with thymoquinone: a new approach for cancer therapy	137
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway	135
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC	124
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery	111
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development	110
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment	103
Slc25a5 regulates adipogenesis by modulating ERK signaling in OP9 cells	99
ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1	93
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges	93
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects	91
lncRNA PVT1: a novel oncogene in multiple cancers	88
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis	78
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review	77
Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis	76
Osteoporosis pathogenesis and treatment: existing and emerging avenues	70
Mitochondrial potassium channels: A novel calcitriol target	66
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L	60
The interaction of canonical Wnt/β-catenin signaling with protein lysine acetylation	59
Melatonin and cancer suppression: insights into its effects on DNA methylation	57
Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells	54
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo	53
Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation	51
COVID-19 therapies: do we see substantial progress?	51
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress	50

METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner	48
Esterase D stabilizes FKBP25 to suppress mTORC1	48
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration	48
Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma	46
Diversification of PAR signaling through receptor crosstalk	45
Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma	45
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications	42
RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop	41
SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells	36
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway	35
Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma	34
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies	34
MicroRNA let-7 and viral infections: focus on mechanisms of action	34
Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro	34
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization	32
Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage	32
The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway	32
RETRACTED ARTICLE:Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway	31
MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30	30
LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability	30
The role of macrophage subtypes and exosomes in immunomodulation	28
The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability	28
Laboratory methods to decipher epigenetic signatures: a comparative review	27
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer	26
The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer	26
Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?	26
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid	25
LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis	25
Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages	25
Correction to: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells	24
Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting	24
Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress	24
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review	23
Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses	23
TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2	23
A rare mutation (p.F149del) of the NT5C3A gene is associated with pyrimidine 5′-nucleotidase deficiency	22
MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer	22
Specificity of H2O2 signaling in leaf senescence: is the ratio of H2O2 contents in different cellular compartments sensed in Arabidopsis plants?	22
Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62–Keap1–NRF2 pathway	22